Amy Ingram, MD
Otolaryngology · Louisville, KYNPI 1588894653
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,119 of the $6,923 with a category attached, or 73.9%. 30 manufacturers reported payments, led by Smith+Nephew at 32.1% of the total. Reporting peaked in 2022 at $1,813 and has fallen 74.2% since, to $467 in 2025. Among otolaryngology clinicians in KY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 181 payments — averaging $38.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$2K
- Inspire Medical Systems, Inc.$1K
- Optinose US, Inc.$533
- Stryker$413
- Regeneron Healthcare Solutions, Inc.$410
- CSL Behring$364
- plus $2K from 24 others
Across 2 payments — averaging $1240.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Smith+Nephew$2K
What the payments were for
- Consulting fees$1,75025%
- Food & beverage$5,11974%
- Education$541%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 8 | $2,224 |
| Inspire Medical Systems, Inc. | 31 | $1,136 |
| Optinose US, Inc. | 34 | $533 |
| Stryker | 14 | $413 |
| Regeneron Healthcare Solutions, Inc. | 9 | $410 |
| CSL Behring | 17 | $364 |
| GSK | 12 | $247 |
| Sanofi | 3 | $180 |
| Integra Lifesciences Corporation | 1 | $150 |
| Hologic Sales And Service, LLC | 1 | $144 |
| Preceptis Medical, Inc. | 1 | $144 |
| Biohaven Pharmaceutical Holding Company Ltd. | 12 | $143 |
| Medtronic | 1 | $114 |
| Lucid Diagnostics Inc. | 1 | $92 |
| AstraZeneca | 5 | $84 |
| Intersect ENT, Inc. | 4 | $80 |
| Teva Pharmaceuticals USA, Inc. | 5 | $75 |
| Lilly USA, LLC | 3 | $58 |
| Resmed Corp | 1 | $54 |
| Amgen | 3 | $45 |
| Pfizer | 3 | $45 |
| Aerin Medical Inc. | 2 | $32 |
| Kaleo, Inc. | 2 | $30 |
| Itamar Medical Inc | 1 | $24 |
| Phathom Pharmaceuticals, Inc. | 2 | $19 |
| Octapharma USA, Inc. | 1 | $18 |
| Alk-abello, Inc | 1 | $17 |
| AbbVie | 1 | $16 |
| Hikma Pharmaceuticals USA | 1 | $16 |
| Neurent Medical Limited | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TULA System$1,050
- TULA$936
- Inspire Upper Airway Stimulation System$504
- DUPIXENT$359
- Halo$187
- Coblation$187
- Acclarent Aera$150
- Inspira Air$150
- RELIEVA SPINPLUS NAV$150
- TruDi Probe$150
- Inspire$148
- CoolSeal Generator$144
- Hummingbird Tympanostomy Tube System$144
- XPRESS ENT DILATION SYSTEM$135
- Xhance$125
- PTeye$114
How this compares
$6,923 in reported general payments places this provider in the 90th percentile of 137 otolaryngology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Epinephrine | 18 | $3,973 |
| Ipratropium Bromide | 92 | $3,156 |
| Azelastine Hcl | 48 | $1,253 |
| Fluticasone Propionate | 65 | $1,048 |
| Ofloxacin | 35 | $1,042 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 11 | $795 |
| Montelukast Sodium | 78 | $579 |
| Esomeprazole Magnesium | 26 | $531 |
| Levothyroxine Sodium | 38 | $489 |
| Omeprazole | 66 | $402 |
| Mupirocin | 54 | $296 |
| Levocetirizine Dihydrochloride | 23 | $283 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 27 | $222 |
| Ondansetron OdtOndansetron | 15 | $117 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 15 | $91 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Hikma Pharmaceuticals USAEpinephrine | $16 | $3,97318 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 137 otolaryngology providers in Kentucky.
Other otolaryngology in Louisville
- Thomas HigginsLouisville$357K
- Andrew GouldLouisville$13K
- Steven ShottsLouisville$12K
- Keith ForwithLouisville$11K
- Skylar TrottLouisville$11K
- Ziad KatribLouisville$7K
- Kevin PottsLouisville$7K
- Gregory AbbasLouisville$6K
- Travis ShuttLouisville$6K
- Matthew YantisLouisville$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.